Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing, and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease, and Alzheimer’s disease. According to the World Health Organization, WHO, more than 700 million cases of psychiatric and neurological disorders are reported every year. These are serious and life-threatening diseases that affect the quality of life of the patients as well as of their relatives. As these diseases also involve major socio-economic costs, it is imperative for the general society that new and innovative pharmaceuticals are developed. Over the past 50 years, new pharmaceuticals have revolutionized the treatment options, but there remains a large unmet need for new and innovative therapeutics. Focus on R&D is the most important pillar in Lundbeck’s ambition to improve treatment for people living with psychiatric and neurological disorders. We are specialists in our area and have research facilities in Denmark and China, and more than 1,000 employees work in our R&D units. We cooperate closely with strategic partners all over the world, ensuring the best possible foundation for innovation and the development of new treatment solutions. Lundbeck employs approximately 5,300 people worldwide, 1,700 of whom are based in Denmark. We have employees in 55 countries, and our products are registered in more than 100 countries. We have production facilities in China, Denmark, France and Italy and research centers in Denmark and China.

Provides research and development services for pharmaceutical preparations

Chengdu Guowei Biopharmaceutical Co., Ltd., established on 2011-11-23, Business scope includes licensed projects:Drug Wholesale;Pharmaceutical commissioned production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;marketing planning;Import and export;Technology Import and Export;Sales of Class II Medical Devices;Healthy food(prepackaged)Sales;Food Internet Sales(Only sell prepackaged food);Specialty Chemicals Sales(Free of Hazardous Chemicals);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology intermediary service(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Beijing Sihuan Pharmaceutical Co. Ltd., a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd., is a company headquartered in China that manufactures pharmaceutical products.

Hainan Sihuan Pharmaceutical Co. Ltd., a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd., is a Chinese company located in Haikou that engages in the research, development and sale of pharmaceutical products.

Tibet Aim Pharm., Inc. engages in the research and development, production, and sale of chemical drugs, and Chinese medicines. Its products include miglitol tablets, gualoupi injections, nalmefene hydrochloride injections, carbetocin injections, hongjin xiaojie tablets, and aceclofenac enteric-coated tablets. The company was founded on December 29, 2007 and is headquartered in Chengdu, China.

Liaoning Haisco Pharmaceutical Co., Ltd., established on 2005-05-19, Business scope includes production:Freeze-dried powder injection,Freeze-dried powder injection(hormones),small volume injection,powder injection(Cephalosporins),large volume injection,large volume injection(Multi-layer co-extrusion infusion bag),API[methylprednisolone succinate(hormones),arginine glutamate,Cinepazide Maleate),Sterile API(Cefmenoxime hydrochloride,Cefotiam Hydrochloride).Chemical materials(Excluding hazardous chemicals and controlled chemicals);Import and transfer of medical technology;R&D and production of formula food for special medical purposes;Import and export of goods and technology.Corporate Image Planning Service;Business Management Consulting Services;Production of pharmaceutical packaging materials.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Zhuhai Tongyuan Pharmaceutical Co., Ltd., established on 1990-05-11, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Disinfectant production(Free of Hazardous Chemicals);Production of Class II Medical Devices;Production of Class III Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Production of Class I Medical Devices;Disinfectant sales(Free of Hazardous Chemicals).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Weihai Henderson Information Technology Development Co., Ltd., established on 2015-04-10, The scope of business includes the development of computer software and automation systems,Sales,Technical service and technology transfer;Information consultation for science and technology projects;Economic Information Consulting;Business Management Consulting.(The scope of business is subject to the approval of the administration for industry and commerce)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Chengdu Easton Bio Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of chemical raw materials and chemical drug preparations. Its products include anti-tumor medicines such as Ubenimex capsules and ibandronate injections; cardiovascular medicines such as bisoprolol fumarate tablets; digestive medicines such as compound glycyrrhizin injections; anesthesia and analgesic products such as nalmefene hydrochloride injections and ibuprofen; and children’s medications. The company was founded by Ying Wang on June 1, 2009 and is headquartered in Chengdu, China.

Cheng Du Tian Tai Shan Zhi Yao Gu Fen You Xian Gong Si, established on 2000-09-29, Business scope includes licensed projects:pharmaceutical production;Drug retail;Drug import and export;road freight transport(Does not contain dangerous goods);Drug Wholesale;Pharmaceutical commissioned production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Production of Chinese herbal extracts;Packaging special equipment manufacturing;Technology Import and Export;Chinese herbal medicine planting;real estate herbal medicine(Does not contain Chinese herbal medicine)buy and sell;Medical Research and Experimental Development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Import and export;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;business management;Business Management Consulting;Commercial Complex Management Services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Wuhan Tongyuan Pharmaceutical Co., Ltd., established on 2003-05-19, Business scope includes Chinese patent medicine,Chemical API,Chemicals,antibiotic preparation,biochemical drug(Does not contain refrigerated and frozen medicines)wholesale;Wholesale and retail of rubber products;drug development;Medical information consultation(Does not include diagnosis and treatment);Biomedical Technology Development,technical consulting,technology transfer;Enterprise Marketing Planning;market survey(Not including business and personal);Trademark agency;Conference and Exhibition Services;industrial design;graphic design,make;Advertising Design,make,acting,release.(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hainan Sihuan Cardiocerebral Vascular Drugs Research Inst., a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd., is a Chinese company located in Haikou that develops pharmaceutical drugs and provides related research and development services. Sihuan Pharmaceutical Holdings Group Ltd. acquired Hainan Sihuan Cardiocerebral Vascular Drugs Research Inst. from Hainan Youbang Fukang Drug Research Co. Ltd. on May 28, 2007 for $0.32 million.

Yunnan Longhai Natural Plant Pharmaceutical Co., Ltd., established on 1999-06-11, Business scope includes Chinese patent medicine,Western medicine,health medicine,Production of National New Drugs,Sales and agency;API(Manufactured under license);Processing of Chinese Herbal Medicine Pieces;Production,Sales:grape seed lozenges,grape seed extract,Grape skin lozenges,Grape Skin Extract;Import and export of goods and technology;Medical Technology Development,Technical Services;Experimental research and development of medical science;Production of disinfection products,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nanjing Zhuokang Pharmaceutical Technology Co., Ltd., established on 2017-03-24, Business scope includes medical technology,biotechnology development,Technology Transfer and Technology Consulting;Class I medical device,Chemical reagents and chemical products(Free of Hazardous Chemicals)technology development and sales;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hisco Pharmaceuticals (Meishan) Co., Ltd., established on 2019-11-14, Business scope includes drug research and development;Technical Services;Import and export of goods or technology;Production,Sales:tablet,Granules,hard capsule,API,medical supplements,ointment(Hormone),cream(Hormone),spray(hormones);Sales of chemical products(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangdong Tongde Pharmaceutical Co., Ltd., established on 2003-09-27, Business scope includes production,Sales:medicine,medical instruments,Face mask,cosmetic,Disinfectant,food,Industrial Flavors and Fragrances,hygiene products,oral hygiene products,Cleaning Products,Daily chemical products,Chemical Products,biological reagent,Daily necessities,Plastic raw materials and products(Does not contain<Banned in Guangdong Province,limit production,Catalog of plastic products sold and used>Prohibition of production in,items for sale),Glass product,test strip;Chinese medicine pretreatment and extraction;Research on new drug products,Development and approval;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval);loading and unloading(Port handling of hazardous chemicals),carry,storage(Storage of Hazardous Chemicals and Hazardous Waste);stem cell technology;Research on immune cell technology,to develop;R&D and achievement transformation services of cell therapy technology;Cell Storage Service;Self-owned property rental service;Health Care Services;Chinese herbal medicine planting,processing,Sales,technology R & D.(All the above business items except hazardous chemicals)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Kebeiyuan (Beijing) Pharmaceutical Technology Co., Ltd., established on 2017-06-14, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Information Technology Consulting Services;Non-residential real estate leases;Chemical product sales(No licensed chemical products);Sales of plastic products;Sales of Class I Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:pharmaceutical production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Beijing Sinopharm Longli Biomedical New Technology Co., Ltd., established on 2004-05-13, Business scope includes legal,Administrative regulations,Prohibited by the decision of the State Council and the national foreign investment industrial policy,Not allowed to operate;law,Administrative regulations,The decision of the State Council stipulates that the project shall be subject to permission and the state's foreign investment industrial policy restricts the operation of the project,It can only be operated after being approved by the examination and approval authority and registered by the industrial and commercial administrative authority;law,Administrative regulations,The decision of the State Council does not stipulate the license and the national foreign investment industrial policy does not restrict the operation,Independently choose business projects to carry out business activities.

ChoiPharm is a drug research and development technology reporting company. They offer generic drug new product development, generic drug consistency evaluation, API and intermediate process development, production and management, raw material drug DMF filing, and other technologies, as well as registration consulting and services.